Covered recipient · General Payments record
ALLISON SCHWEDELSON
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$2,097.99
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $638.94 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $223.00 | 10 |
| Almirall LLC | $146.45 | 8 |
| GENZYME CORPORATION | $103.43 | 4 |
| Regeneron Healthcare Solutions, Inc. | $71.37 | 2 |
| REVANCE THERAPEUTICS, INC. | $46.77 | 1 |
| Arcutis Biotherapeutics, Inc. | $17.64 | 1 |
| Galderma Laboratories, L.P. | $16.29 | 1 |
| Hill Dermaceuticals, Inc. | $13.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $36.17 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046392 | CMS |
| ABBVIE INC. | $25.99 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046394 | CMS |
| ABBVIE INC. | $31.00 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046396 | CMS |
| ABBVIE INC. | $6.30 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046398 | CMS |
| ABBVIE INC. | $17.45 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046400 | CMS |
| ABBVIE INC. | $19.25 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046402 | CMS |
| ABBVIE INC. | $13.50 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046404 | CMS |
| ABBVIE INC. | $33.96 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046406 | CMS |
| ABBVIE INC. | $5.22 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046408 | CMS |
| ABBVIE INC. | $34.16 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046410 | CMS |
| Almirall LLC | $15.72 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639814 | CMS |
| Almirall LLC | $11.16 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639816 | CMS |
| Almirall LLC | $27.87 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639860 | CMS |
| Almirall LLC | $27.91 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639862 | CMS |
| Almirall LLC | $32.10 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639878 | CMS |
| Almirall LLC | $4.00 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639880 | CMS |
| Almirall LLC | $2.50 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639918 | CMS |
| Almirall LLC | $25.19 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120639920 | CMS |
| Arcutis Biotherapeutics, Inc. | $17.64 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121033866 | CMS |
| Galderma Laboratories, L.P. | $16.29 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145326976 | CMS |
| GENZYME CORPORATION | $32.55 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139585690 | CMS |
| GENZYME CORPORATION | $29.48 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139585720 | CMS |
| GENZYME CORPORATION | $17.90 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139585760 | CMS |
| GENZYME CORPORATION | $23.50 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139585786 | CMS |
| Hill Dermaceuticals, Inc. | $13.99 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1065461413 | CMS |
| Regeneron Healthcare Solutions, Inc. | $36.60 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114164518 | CMS |
| Regeneron Healthcare Solutions, Inc. | $34.77 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114164523 | CMS |
| REVANCE THERAPEUTICS, INC. | $46.77 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147928809 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.